The Role of Cholesterol in Chronic Lymphocytic Leukemia Development and Pathogenesis

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)
70 Downloads (Pure)


Cholesterol has many critical functions in cells. It is a key component of membranes and cell-signalling processes, and it functions as a chemical precursor in several biochemical pathways, such as Vitamin D and steroid synthesis. Cholesterol has also been implicated in the development and progression of various cancers, in which it is thought to promote cell proliferation, migration, and invasion. Chronic lymphocytic leukemia (CLL) is an example of a lipid-avid cancer that relies on lipid metabolism, rather than glycolysis, to fuel cell proliferation. However, data regarding the role of cholesterol in CLL are conflicting. Studies have shown that dyslipidaemia is more common among CLL patients than age-matched healthy controls, and that CLL patients who take cholesterol-lowering drugs, such as statins, appear to have improved survival rates. Therefore, defining the roles of cholesterol in CLL may highlight the importance of monitoring and managing hyperlipidaemia as part of the routine management of patients with CLL. In this review, we discuss the roles of cholesterol in the context of CLL by examining the literature concerning the trafficking, uptake, endogenous synthesis, and intracellular handling of this lipid. Data from clinical trials investigating various classes of cholesterol and lipid-lowering drugs in CLL are also discussed.

Original languageEnglish
Article number799
Number of pages19
Issue number7
Early online date27 Jun 2023
Publication statusPublished - Jul 2023


  • cancer
  • chronic lymphocytic leukemia (CLL)
  • dyslipidemia
  • HDL
  • LDL
  • statins


Dive into the research topics of 'The Role of Cholesterol in Chronic Lymphocytic Leukemia Development and Pathogenesis'. Together they form a unique fingerprint.

Cite this